Post by Dicot Pharma AB

The terms are now set! Subscription period for our right issue is during May 21 to June 4. Existing shareholders have preferential rights to subscribe for shares, while new investors may also register their interest in participating. The subscription price is SEK 1.36 per unit, corresponding to SEK 0.17 per share. SEK 168 million is already secured through subscription commitments and guarantee undertakings, ensuring funding for the upcoming phase 2b study and advancing LIB-01 toward out-licensing and partnership opportunities. To access all terms and conditions, please visit: https://lnkd.in/gki26_Ty Or, read the press release: https://lnkd.in/gFXT_fEs Follow us for updates on our journey 🚀 #DicotPharma #LIB01 #biotech #investors #erectiledysfunction